SHFG
REGN icon

S Harris Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

S Harris Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204K Buy
327
+57
+21% +$38.8K 0.16% 117
2026
Q1 		$209K Buy
+270
New +$207K 0.19% 99

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

S Harris Financial Group's REGN Position: Q2 2026 in Review

S Harris Financial Group increased its Regeneron Pharmaceuticals (REGN) stake by 21% in Q2 2026, buying an estimated $38.8K and bringing the position to 327 shares worth $204K. The position accounts for 0.16% of the portfolio, ranked #117.

S Harris Financial Group first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $209K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • S Harris Financial Group held 327 shares of Regeneron Pharmaceuticals worth $204K as of Q2 2026.
  • S Harris Financial Group bought 57 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $38.8K.
  • Regeneron Pharmaceuticals made up 0.16% of S Harris Financial Group's portfolio in Q2 2026, its #117 holding.
  • S Harris Financial Group first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • S Harris Financial Group's Regeneron Pharmaceuticals position peaked at $209K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on S Harris Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.